Antimicrobial Resistance (AMR)

What is Antimicrobial Resistance (AMR)?

AMR occurs when microorganisms (bacteria, fungi, viruses, and parasites) evolve to resist the effects of medications that once killed them. This makes infections harder to treat and increases the risk of disease spread, severe illness, and death.

Causes of AMR

Overuse and misuse of antimicrobials in humans and animals.
Poor infection prevention and control in healthcare settings.
Lack of clean water, sanitation, and hygiene.
Global travel and trade, which spread resistant strains.
Environmental contamination from pharmaceutical manufacturing and agriculture.

Global Impact

4.95 million deaths were associated with bacterial AMR in 2019, with 1.27 million directly attributable.
AMR threatens the success of surgeries, cancer treatments, and organ transplants.
It poses a major economic burden, especially in low- and middle-income countries.

Global Strategies to Combat AMR

1. WHO Global Action Plan

Improve awareness and education.
Strengthen surveillance and research.
Reduce infection incidence.
Optimize antimicrobial use.
Invest in sustainable alternatives.

2. One Health Approach

Integrates human, animal, and environmental health.
Promotes cross-sector collaboration.

3. WHO’s 40 Research Priorities (2023)

Focus on diagnostics, treatment regimens, and implementation science.
Emphasis on cost-effective strategies for LMICs.

Research Trends & Innovations

AI & Machine Learning: Used to predict resistance patterns and design new drugs.
Phage Therapy: Viruses that target bacteria are being explored as alternatives.
CRISPR-based tools: For precision targeting of resistant genes.
Global AMR R&D Hub: Tracks over €8.2 billion in investments (2017–2021), highlighting gaps in non-human and non-bacterial research.
Australia’s AMR Lens Report: Showcases innovations in diagnostics, vaccines, and stewardship programs.

Latest Research Highlights

Chronic Diseases & AMR: AMR is increasingly problematic in patients with chronic lung diseases like cystic fibrosis and COPD, where long-term antibiotic use fosters resistance.
Cancer & AMR: Cancer patients, especially those undergoing chemotherapy, are more susceptible to resistant infections, making AMR a growing crisis in oncology care.
Global Mortality Forecast: A study in The Lancet estimates that AMR could cause over 39 million deaths by 2050, with a sharp rise in elderly populations.

Global Initiatives & Funding

WHO’s Global Research Agenda (2023):
- Identifies 40 priority research areas to be addressed by 2030.
- Focuses on diagnostics, treatment regimens, surveillance, and policy implementation, especially in low- and middle-income countries.
Major Funders & Programs:
- CARB-X: Supports early-stage antibiotic R&D.
- Fleming Fund: Focuses on surveillance and lab capacity in LMICs.
- Wellcome Trust, Gates Foundation, Novo Nordisk Foundation: Fund discovery and translational research.
Scholarships & Fellowships:
- Numerous PhD and postdoc opportunities are available globally, including in AI-assisted antimicrobial design, biofilm research, and nanomedicine.

Key Challenges in AMR Research

Overuse & Misuse of Antibiotics:
- In both human medicine and agriculture, this remains the primary driver of resistance.
Lack of New Antibiotics:
- The antibiotic pipeline is drying up due to high R&D costs and low commercial incentives.
Surveillance Gaps:
- Many countries lack robust systems to track resistance patterns, especially in rural and under-resourced areas.
Policy & Implementation Barriers:
- Translating research into effective policy remains a major hurdle, especially in fragmented healthcare systems.

Breakthrough Strategies

AI & Big Data: Used to predict resistance patterns and design new antimicrobials.
Phage Therapy: Gaining traction as a potential alternative to antibiotics.
One Health Approach: Integrates human, animal, and environmental health to tackle AMR holistically.

Terms to know

Germs are microbes—very small living organisms including bacteria, fungi, parasites and viruses.
Pathogens are germs that cause infections. Most germs are harmless and even helpful to people.
Bacteria cause infections such as strep throat, foodborne illnesses, and other serious infections.
Fungi cause infections like athlete’s foot, yeast infections, and other serious infections.
Antibiotics are medicines that fight infections caused by bacteria in humans and animals by either killing the bacteria or making it difficult for the bacteria to grow and multiply.
Antifungals are medicines that treat fungal infections by killing or stopping the growth of dangerous fungi in humans, animals or plants.
People sometimes use “antibiotic” and “antimicrobial” interchangeably.